Stomatitis: Clinical Trials

6 trials for Stomatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown, 1 withdrawn. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Completed 4, Unknown 1, Withdrawn 1

Follow Stomatitis: new trials by email Literature Review of Stomatitis trials Research Report on Stomatitis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of a New Medical Device for Oral Mucositis
Bocaliner - Oral Mucositis, Stem Cell Transplant Complications
Early Phase 1WithdrawnE2Bio Life Sciences, LLC2024-11-302026-09-11
Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
Abrocitinib, Tofacitinib - Toxic Epidermal Necrolysis
Early Phase 1UnknownPeng Zhang302023-07-052023-11-28
Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients
Hydrogen tablets, Control - Mucositis Oral
Early Phase 1CompletedStony Brook University242022-05-252025-05-14
Low Level Laser Therapy Versus Benzydamin in Prevention and Treatment of Oral Mucositis
0.15% bezaydamine hydrochloride., low power laser with a wavelength of 870 nm - Stomatitis (Oral Mucositis)
Early Phase 1CompletedAl-Azhar University902021-10-052022-03-22
Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis
Combination of diclofenac potassium and propolis, placebo - Oral Mucositis, ORAS
Early Phase 1CompletedAl-Azhar University1002021-06-012023-07-21
Effect of Alum Stone Containing Mucosal Adhesive Patches on Healing of Recurrent Aphthous Stomatitis
Size of aphthous lesions and degree of pain assessed at days 1, 3, and 5., Control, ALUMSTONE - Aphthous Stomatitis, Recurrent, Aphthous Stomatitis
Early Phase 1CompletedUniversity Of Anbar1002021-02-052025-05-07

Narrower conditions

Head and Neck Neoplasms (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Oral Ulcer (1)  ·  Stevens-Johnson Syndrome (1)  ·  Stomatitis, Aphthous (1)  ·  Sutton disease 2 (1)

Broader conditions

Stomatognathic Diseases (6)  ·  Mouth Diseases (5)  ·  Chemically-Induced Disorders (1)  ·  Dermatitis (1)  ·  Drug Eruptions (1)  ·  Drug Hypersensitivity (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Erythema (1)  ·  Erythema Multiforme (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Delayed (1)  ·  Immune System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Hydrogen (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Propolis (1)  ·  abrocitinib (1)  ·  tofacitinib (1)

Sponsors

Al-Azhar University (2)  ·  E2Bio Life Sciences, LLC (1)  ·  Peng Zhang (1)  ·  Stony Brook University (1)  ·  University Of Anbar (1)

Countries

Egypt (2)  ·  Armenia (1)  ·  China (1)  ·  Iraq (1)  ·  United States (1)

Top investigators

Ashraf I Gaafar, professor (1)  ·  Kartik Mani, MD (1)  ·  Yervand Hakoban, MD PhD (1)

Results publications

PMID 16601950, PMID 18298885, PMID 24615748, PMID 26409924, PMID 30990550